GBDC Stock +24.76% Since The Golden Star Was Identified GBDC Stock +24.76% Since The Golden Star Was Identified Unlock Golden Star List

Range Low Price High Price Comment
30 days $4.61 $5.48 Thursday, 18th Apr 2024 QURE stock ended at $4.71. This is 0.86% more than the trading day before Wednesday, 17th Apr 2024. During the day the stock fluctuated 2.26% from a day low at $4.66 to a day high of $4.76.
90 days $4.61 $6.85
52 weeks $4.61 $22.48

Historical uniQure N.V. prices

Date Open High Low Close Volume
2021-09-16 $36.29 $37.23 $36.10 $36.80 667 167
2021-09-15 $36.32 $37.67 $36.26 $36.38 727 645
2021-09-14 $35.36 $36.68 $35.25 $36.39 715 269
2021-09-13 $35.44 $35.97 $35.13 $35.24 633 199
2021-09-10 $35.66 $35.98 $34.45 $35.12 776 075
2021-09-09 $34.72 $35.80 $34.62 $35.47 759 216
2021-09-08 $34.70 $35.38 $34.48 $34.69 955 820
2021-09-07 $34.47 $35.37 $33.76 $34.94 2 341 067
2021-09-03 $31.25 $31.48 $30.74 $31.11 464 819
2021-09-02 $29.70 $31.41 $29.51 $31.29 720 169
2021-09-01 $29.24 $30.08 $28.73 $29.47 730 194
2021-08-31 $28.69 $29.70 $28.69 $29.00 563 600
2021-08-30 $29.52 $29.85 $28.70 $28.71 408 689
2021-08-27 $28.48 $29.55 $28.46 $29.37 420 365
2021-08-26 $28.84 $28.99 $28.03 $28.43 250 508
2021-08-25 $28.63 $28.96 $28.03 $28.80 375 441
2021-08-24 $28.75 $28.75 $27.30 $28.15 320 242
2021-08-23 $26.68 $28.34 $26.52 $28.04 669 034
2021-08-20 $26.65 $27.43 $26.46 $26.80 724 957
2021-08-19 $27.34 $27.78 $26.42 $26.49 376 784
2021-08-18 $28.79 $28.91 $27.52 $27.68 319 962
2021-08-17 $28.42 $29.03 $28.08 $29.02 275 026
2021-08-16 $28.84 $29.15 $28.25 $28.55 261 767
2021-08-13 $29.39 $29.62 $29.01 $29.16 163 868
2021-08-12 $29.96 $29.97 $29.11 $29.30 220 352
Click to get the best stock tips daily for free!

About uniQure N.V.

uniQure N.V. uniQure N.V., a gene therapy company, engages in the development of treatments for patients suffering from genetic and other devastating diseases. Its lead program is Etranacogene dezaparvovec (AMT-061), which is in Phase III HOPE-B pivotal trial for the treatment of hemophilia B. The company also engages in developing AMT-130, a gene therapy that is in Phase I/II clinical study for the treatment of Huntington's disease; AMT-060, which is in Phas... QURE Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT